Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cynosure Inc Receives Health Canada Authorization To Market Picosure, The First Picosecond Laser To Remove Tattoos And Benign Pigmented Lesions


Monday, 29 Jul 2013 08:35am EDT 

Cynosure Inc announced that it has received a medical device license issued by Health Canada for the Company's PicoSure Picosecond Laser Workstation. Cynosure plans to begin selling PicoSure through its North American direct sales force immediately. The device received 510(k) clearance from the U.S. Food and Drug Administration at the end of 2012 and was launched in the first quarter of 2013. PicoSure received CE Mark certification in first quarter of 2013, and is currently being marketed in the European Union. 

Company Quote

23.08
-0.08 -0.35%
12:37pm EDT